S'abonner

Association of Discharge Home with Home Health Care and 30-Day Readmission after Pancreatectomy - 18/10/14

Doi : 10.1016/j.jamcollsurg.2014.07.008 
Dominic E. Sanford, MD, MPHS a, e, Margaret A. Olsen, PhD, MPH d, f, Kerry M. Bommarito, PhD d, f, Manish Shah, MD b, g, Ryan C. Fields, MD, FACS a, e, h, William G. Hawkins, MD, FACS a, e, h, David P. Jaques, MD, FACS c, David C. Linehan, MD, FACS a, e, h,
a Department of Surgery, Barnes-Jewish Hospital, St Louis, MO 
b Department of Neurosurgery, Barnes-Jewish Hospital, St Louis, MO 
c Department of Surgical Services, Barnes-Jewish Hospital, St Louis, MO 
d Division of Public Health Sciences, Washington University School of Medicine, St Louis, MO 
e Department of Surgery, Washington University School of Medicine, St Louis, MO 
f Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, MO 
g Department of Neurosurgery, Washington University School of Medicine, St Louis, MO 
h Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 

Correspondence address: David C Linehan, MD, FACS, Department of Surgery, Washington University in Saint Louis, 4990 Children's Pl, Ste 1160, Box 8109, St Louis, MO 63110.

Abstract

Background

We sought to determine if discharge home with home health care (HHC) is an independent predictor of increased readmission after pancreatectomy.

Study Design

We examined 30-day readmissions in patients undergoing pancreatectomy using the Healthcare Cost and Utilization Project State Inpatient Database for California from 2009 to 2011. Readmissions were categorized as severe or nonsevere using the Modified Accordion Severity Grading System. Multivariable logistic regression models were used to examine the association of discharge home with HHC and 30-day readmission using discharge home without HHC as the reference group. Propensity score matching was used as an additional analysis to compare the rate of 30-day readmission between patients discharged home with HHC with patients discharged home without HHC.

Results

Of 3,573 patients who underwent pancreatectomy, 752 (21.0%) were readmitted within 30 days of discharge. In a multivariable logistic regression model, discharge home with HHC was an independent predictor of increased 30-day readmission (odds ratio = 1.37; 95% CI, 1.11–1.69; p = 0.004). Using propensity score matching, patients who received HHC had a significantly increased rate of 30-day readmission compared with patients discharged home without HHC (24.3% vs 19.8%; p < 0.001). Patients discharged home with HHC had a significantly increased rate of nonsevere readmission compared with those discharged home without HHC, by univariate comparison (19.2% vs 13.9%; p < 0.001), but not severe readmission (6.4% vs 4.7%; p = 0.08). In multivariable logistic regression models, excluding patients discharged to facilities, discharge home with HHC was an independent predictor of increased nonsevere readmissions (odds ratio = 1.41; 95% CI, 1.11–1.79; p = 0.005), but not severe readmissions (odds ratio = 1.31; 95% CI, 0.88–1.93; p = 0.18).

Conclusions

Discharge home with HHC after pancreatectomy is an independent predictor of increased 30-day readmission; specifically, these services are associated with increased nonsevere readmissions, but not severe readmissions.

Le texte complet de cet article est disponible en PDF.

Abbreviations and Acronyms : HCUP, HHC, OR, SID


Plan


 Disclosure Information: Nothing to disclose.
 Support: This study was supported by the NCI grant T32 CA 009621.


© 2014  American College of Surgeons. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 219 - N° 5

P. 875 - novembre 2014 Retour au numéro
Article précédent Article précédent
  • Optimizing Risk Stratification in Portal Vein Thrombosis after Splenectomy and its Primary Prophylaxis with Antithrombin III Concentrates and Danaparoid Sodium in Liver Cirrhosis with Portal Hypertension
  • Hirofumi Kawanaka, Tomohiko Akahoshi, Shinji Itoh, Tomohiro Iguchi, Norifumi Harimoto, Hideaki Uchiyama, Tomoharu Yoshizumi, Ken Shirabe, Kenji Takenaka, Yoshihiko Maehara
| Article suivant Article suivant
  • Acoustic Radiation Force Impulse Imaging of the Pancreas for Estimation of Pathologic Fibrosis and Risk of Postoperative Pancreatic Fistula
  • Nobuhiro Harada, Takeaki Ishizawa, Yosuke Inoue, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Yasuhiko Sugawara, Mariko Tanaka, Masashi Fukayama, Norihiro Kokudo

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.